Analysis reveals elevated ECM1 and LRP1 levels linked to cardiac fibrosis in heart failure patients, suggesting possible biomarkers.
Circulating ECM1 and LRP1 levels are elevated in chronic HF and are closely associated with cardiac dysfunction and fibrosis. These findings suggest that ECM1 and LRP1 could serve as novel biomarkers for myocardial remodeling, with potential utility in the risk stratification and monitoring of patients with HF.
No takes yet. Share an insight, caveat, or question.
Han Zhongyuan (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: